应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ARVN Arvinas Holding Company LLC
交易中 02-25 14:46:43 EST
13.16
+0.79
+6.39%
最高
13.68
最低
12.57
成交量
87.45万
今开
12.98
昨收
12.37
日振幅
8.97%
总市值
8.45亿
流通市值
8.45亿
总股本
6,422万
成交额
1,170万
换手率
1.36%
流通股本
6,422万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Arvinas将于2026年2月24日公布2025年第四季度及全年财务业绩
投资观察 · 02-17
Arvinas将于2026年2月24日公布2025年第四季度及全年财务业绩
Arvinas任命Randy Teel博士为总裁、首席执行官兼董事
投资观察 · 02-12
Arvinas任命Randy Teel博士为总裁、首席执行官兼董事
Arvinas任命Randy Teel博士为总裁、首席执行官兼董事
美股速递 · 02-12
Arvinas任命Randy Teel博士为总裁、首席执行官兼董事
Arvinas, Inc.盘中异动 股价大跌5.13%
市场透视 · 02-11
Arvinas, Inc.盘中异动 股价大跌5.13%
Arvinas公布有关Vepdegestrant(Arv-471)临床开发项目的数据展示,参加2025年圣安东尼奥乳腺癌研讨会(Sabcs)
美股速递 · 2025-11-24
Arvinas公布有关Vepdegestrant(Arv-471)临床开发项目的数据展示,参加2025年圣安东尼奥乳腺癌研讨会(Sabcs)
Arvinas第三季度收入为4190万美元
投资观察 · 2025-11-20
Arvinas第三季度收入为4190万美元
创新药重磅! Arvinas(ARVN.US)携辉瑞(PFE.US)推进“乳腺癌ER降解剂”第三方商业化
智通财经 · 2025-09-18
创新药重磅! Arvinas(ARVN.US)携辉瑞(PFE.US)推进“乳腺癌ER降解剂”第三方商业化
辉瑞乳腺癌新药Vepdegestrant研究喜忧参半,授权方Arvinas股价暴跌40%
智通财经网 · 2025-03-11
辉瑞乳腺癌新药Vepdegestrant研究喜忧参半,授权方Arvinas股价暴跌40%
Arvinas, Inc.盘中异动 下午盘股价大跌5.14%报17.34美元
市场透视 · 2025-03-11
Arvinas, Inc.盘中异动 下午盘股价大跌5.14%报17.34美元
花旗:维持Arvinas(ARVN.US)评级,由中性调整至中性评级, 目标价由28.00美元调整至19.00美元。
金融界 · 2025-03-08
花旗:维持Arvinas(ARVN.US)评级,由中性调整至中性评级, 目标价由28.00美元调整至19.00美元。
Arvinas, Inc.盘中异动 下午盘急速拉升5.20%
市场透视 · 2025-03-07
Arvinas, Inc.盘中异动 下午盘急速拉升5.20%
Arvinas, Inc.盘中异动 早盘股价大涨5.12%
市场透视 · 2025-03-05
Arvinas, Inc.盘中异动 早盘股价大涨5.12%
Arvinas, Inc.盘中异动 下午盘股价大跌5.14%报16.79美元
市场透视 · 2025-03-04
Arvinas, Inc.盘中异动 下午盘股价大跌5.14%报16.79美元
Arvinas, Inc.盘中异动 大幅拉升5.08%报18.01美元
市场透视 · 2025-02-28
Arvinas, Inc.盘中异动 大幅拉升5.08%报18.01美元
Arvinas, Inc.盘中异动 临近午盘急速跳水5.09%报16.77美元
市场透视 · 2025-02-27
Arvinas, Inc.盘中异动 临近午盘急速跳水5.09%报16.77美元
Arvinas, Inc.盘中异动 临近收盘股价大涨5.01%
市场透视 · 2025-02-26
Arvinas, Inc.盘中异动 临近收盘股价大涨5.01%
Arvinas, Inc.盘中异动 股价大跌5.21%报16.85美元
市场透视 · 2025-02-24
Arvinas, Inc.盘中异动 股价大跌5.21%报16.85美元
Arvinas, Inc.盘中异动 股价大跌5.01%
市场透视 · 2025-02-22
Arvinas, Inc.盘中异动 股价大跌5.01%
Arvinas, Inc.盘中异动 快速拉升5.30%
市场透视 · 2025-02-18
Arvinas, Inc.盘中异动 快速拉升5.30%
Arvinas, Inc.2024财年实现净利润-1.99亿美元,同比增加45.78%
市场透视 · 2025-02-15
Arvinas, Inc.2024财年实现净利润-1.99亿美元,同比增加45.78%
暂无数据
公司概况
公司名称:
Arvinas Holding Company LLC
所属市场:
NASDAQ
上市日期:
--
主营业务:
Arvinas, Inc.于2013年2月根据特拉华州法律成立。该公司是一家生物制药公司,致力于通过发现、开发和商业化治疗降低致病蛋白质来改善患有衰弱和危及生命的疾病的患者的生活。该公司使用他们的专有技术平台来设计针对嵌合体或PROTAC的蛋白水解,这些嵌合体旨在利用人体自身的天然蛋白质处理系统来选择性地和有效地降解和去除致病蛋白质。Arvinas Holding Company,LLC相信他们的靶向蛋白质降解方法是一种新的治疗方式,可能提供优于现有方式的独特优势,包括传统的小分子疗法和基于基因的药物。
发行价格:
--
{"stockData":{"symbol":"ARVN","market":"US","secType":"STK","nameCN":"Arvinas Holding Company LLC","latestPrice":13.16,"timestamp":1772048796682,"preClose":12.37,"halted":0,"volume":874472,"delay":0,"changeRate":0.06386418755052554,"floatShares":64224294,"shares":64224294,"eps":-1.2161,"marketStatus":"交易中","change":0.79,"latestTime":"02-25 14:46:43 EST","open":12.98,"high":13.68,"low":12.57,"amount":11698710.901216,"amplitude":0.089733,"askPrice":13.16,"askSize":205,"bidPrice":13.14,"bidSize":69,"shortable":0,"etf":0,"ttmEps":-1.2161,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772053200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1538020800000,"exchange":"NASDAQ","adjPreClose":12.37,"preHourTrading":{"tag":"盘前","latestPrice":12.86,"preClose":12.37,"latestTime":"09:29 EST","volume":5893,"amount":73027.287637,"timestamp":1772029799958,"change":0.49,"changeRate":0.039612,"amplitude":0.092967},"postHourTrading":{"tag":"盘后","latestPrice":12.37,"preClose":12.37,"latestTime":"18:31 EST","volume":19896,"amount":246084,"timestamp":1771975908595,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.027699,"impliedVol":0.7624,"impliedVolPercentile":0.498},"requestUrl":"/m/hq/s/ARVN/tweets","defaultTab":"tweets","newsList":[{"id":"1155813114","title":"Arvinas将于2026年2月24日公布2025年第四季度及全年财务业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1155813114","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155813114?lang=zh_cn&edition=full","pubTime":"2026-02-17 20:04","pubTimestamp":1771329862,"startTime":"0","endTime":"0","summary":"康涅狄格州纽黑文,2026年2月17日——临床阶段生物技术公司Arvinas, Inc.今日宣布,公司管理层将于2026年2月24日(星期二)美国东部时间上午8:00举行网络直播,回顾2025年第四季度及全年财务业绩,并提供公司最新动态。此次网络直播可通过Arvinas官方网站投资者关系页面的\"活动与演示\"栏目观看。Arvinas是一家临床阶段的生物技术公司,致力于改善患有衰弱性和危及生命疾病的患者的生活。Arvinas公司总部位于康涅狄格州纽黑文。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ARVN"],"gpt_icon":0},{"id":"1186467262","title":"Arvinas任命Randy Teel博士为总裁、首席执行官兼董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1186467262","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186467262?lang=zh_cn&edition=full","pubTime":"2026-02-12 20:06","pubTimestamp":1770898006,"startTime":"0","endTime":"0","summary":"Arvinas公司今日宣布,任命Randy Teel博士担任公司总裁兼首席执行官,并进入董事会,即日生效。Teel博士此前担任Arvinas首席商务官,以其推动企业成长与行业合作的战略领导力著称。此次人事变动源于原总裁兼首席执行官John Houston博士退休。同日,Briggs Morrison博士当选为董事会主席。在加入Arvinas前,他曾任Alexion Pharmaceuticals战略副总裁及麦肯锡公司副合伙人。Arvinas是一家临床阶段生物技术公司,致力于通过PROTAC蛋白降解技术平台开发创新疗法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","IPO","CEO","ARVN"],"gpt_icon":0},{"id":"1101957887","title":"Arvinas任命Randy Teel博士为总裁、首席执行官兼董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1101957887","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101957887?lang=zh_cn&edition=full","pubTime":"2026-02-12 20:02","pubTimestamp":1770897721,"startTime":"0","endTime":"0","summary":"Arvinas Holding Company LLC宣布,任命Randy Teel博士担任公司总裁、首席执行官及董事职务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2610946885","title":"Arvinas, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610946885","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610946885?lang=zh_cn&edition=full","pubTime":"2026-02-11 22:51","pubTimestamp":1770821466,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日22时51分,Arvinas, Inc.股票出现波动,股价快速下跌5.13%。Arvinas, Inc.股票所在的生物技术行业中,整体跌幅为0.93%。Arvinas, Inc.公司简介:Arvinas Inc 是一家总部位于美国的生物制药公司,致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021122510797a5d2d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021122510797a5d2d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ARVN"],"gpt_icon":0},{"id":"1163182464","title":"Arvinas公布有关Vepdegestrant(Arv-471)临床开发项目的数据展示,参加2025年圣安东尼奥乳腺癌研讨会(Sabcs)","url":"https://stock-news.laohu8.com/highlight/detail?id=1163182464","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163182464?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:02","pubTimestamp":1763985764,"startTime":"0","endTime":"0","summary":"Arvinas公布有关Vepdegestrant(Arv-471)临床开发项目的数据展示,参加2025年圣安东尼奥乳腺癌研讨会(Sabcs)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505439.SGD","LU1894683348.USD","BK4599","LU0289739699.SGD","LU0170899867.USD","BK4581","BK4007","IE00BBT3K403.USD","BK4533","ARVN","LU0234572021.USD","LU0985481810.HKD","BK4588","SG9999003800.SGD","BK4592","IE00BLSP4452.SGD","SG9999001176.SGD","LU0456855351.SGD","LU0225771236.USD","LU0122379950.USD","LU1066051498.USD","LU1023059063.AUD","PFE","LU0058720904.USD","LU1894683264.USD","SG9999002224.SGD","LU1883839398.USD","LU0868494617.USD","IE00B19Z3581.USD","LU1057294990.SGD","BK4550","LU0225284248.USD","SGXZ57979304.SGD","LU1066053197.SGD","BK4585","IE00B19Z3B42.SGD","SG9999013999.USD","SG9999002232.USD","IE000M9KFDE8.USD","BK4568","LU0306807586.USD","LU0306806265.USD","BK4534","LU0321505868.SGD","SG9999001176.USD","IE0002270589.USD","IE00BLSP4239.USD","SG9999011175.SGD"],"gpt_icon":0},{"id":"1171799889","title":"Arvinas第三季度收入为4190万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1171799889","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171799889?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:41","pubTimestamp":1763570505,"startTime":"0","endTime":"0","summary":"11月5日 - Arvinas第三季度运营开支为8570万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2568942697","title":"创新药重磅! Arvinas(ARVN.US)携辉瑞(PFE.US)推进“乳腺癌ER降解剂”第三方商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2568942697","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568942697?lang=zh_cn&edition=full","pubTime":"2025-09-18 14:32","pubTimestamp":1758177173,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,美国生物科技新势力Arvinas以及合作伙伴医药巨头辉瑞已决定将重磅创新药vepdegestrant 的商业化权利对外授权——即决定将该药物的商业化权利对外转授权,该药是一种用于乳腺癌的在研雌激素受体蛋白降解剂。据了解,Arvinas 在一份新闻稿中表示,授权交由第三方的商业化举措“是释放vepdegestrant的全部价值并确保若获监管机构批准即可及时向市场供应的最佳前进路径”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3d5e617fa4201a4d118497eca86af802","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1346711.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE0002270589.USD","SG9999001176.USD","BK4568","SG9999002232.USD","BK4534","LU0868494617.USD","LU1057294990.SGD","LU1894683264.USD","LU0321505868.SGD","BK4599","LU0225284248.USD","LU0225771236.USD","PFE","SG9999001176.SGD","ARVN","LU0122379950.USD","BK4588","IE00BLSP4452.SGD","SG9999013999.USD","LU0058720904.USD","BK4533","LU0289739699.SGD","LU1023059063.AUD","BK4550","LU0321505439.SGD","IE00B19Z3B42.SGD","BK4585","SG9999011175.SGD","BK1161","IE00BBT3K403.USD","SGXZ57979304.SGD","LU0170899867.USD","BK4007","LU1883839398.USD","LU1066053197.SGD","LU0985481810.HKD","BK4592","BK1574","LU0234572021.USD","LU0306806265.USD","06978","IE00BLSP4239.USD","LU1894683348.USD","BK4581","SG9999003800.SGD","LU0306807586.USD","LU1066051498.USD","LU0456855351.SGD","IE000M9KFDE8.USD","159992"],"gpt_icon":1},{"id":"2518745334","title":"辉瑞乳腺癌新药Vepdegestrant研究喜忧参半,授权方Arvinas股价暴跌40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518745334","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518745334?lang=zh_cn&edition=full","pubTime":"2025-03-11 20:59","pubTimestamp":1741697953,"startTime":"0","endTime":"0","summary":"辉瑞公司的下一代乳腺癌治疗药物 vepdegestrant 在最后阶段的研究中取得了好坏参半的结果,未能延缓所有患者的癌症进展,但达到了针对具有特定基因突变的亚组患者的目标。","market":"sh","thumbnail":"https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1260559.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4568","LU0985481810.HKD","SG9999002224.SGD","IE0002270589.USD","BK4592","LU1066051498.USD","IE00B19Z3B42.SGD","SG9999002232.USD","PFE","BK4585","LU1066053197.SGD","SG9999013999.USD","LU0306807586.USD","LU0225771236.USD","BK4588","SG9999003800.SGD","BK4007","LU0225284248.USD","LU1894683348.USD","LU0321505439.SGD","LU1023059063.AUD","BK4550","LU0058720904.USD","LU0456855351.SGD","ARVN","LU0122379950.USD","LU1894683264.USD","LU0170899867.USD","LU1057294990.SGD","IE00BLSP4452.SGD","SGXZ57979304.SGD","BK4533","IE00BLSP4239.USD","BK4581","SG9999001176.USD","IE00B19Z3581.USD","BK4534","SG9999011175.SGD","LU0289739699.SGD","LU0868494617.USD","LU0306806265.USD","BK4599","IE000M9KFDE8.USD","LU0234572021.USD","LU0321505868.SGD","IE00BBT3K403.USD","LU1883839398.USD","SG9999001176.SGD"],"gpt_icon":1},{"id":"2518495206","title":"Arvinas, Inc.盘中异动 下午盘股价大跌5.14%报17.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518495206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518495206?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:13","pubTimestamp":1741630432,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时13分,Arvinas, Inc.股票出现异动,股价急速下挫5.14%。截至发稿,该股报17.34美元/股,成交量57.7109万股,换手率0.84%,振幅6.04%。Arvinas, Inc.股票所在的生物技术行业中,整体涨幅为0.68%。Arvinas, Inc.公司简介:Arvinas Inc 是一家总部位于美国的生物制药公司,致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102135298a2d48d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102135298a2d48d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ARVN"],"gpt_icon":0},{"id":"2517693254","title":"花旗:维持Arvinas(ARVN.US)评级,由中性调整至中性评级, 目标价由28.00美元调整至19.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517693254","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517693254?lang=zh_cn&edition=full","pubTime":"2025-03-08 05:50","pubTimestamp":1741384237,"startTime":"0","endTime":"0","summary":"花旗:维持Arvinas(ARVN.US)评级,由中性调整至中性评级, 目标价由28.00美元调整至19.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08055048605286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARVN"],"gpt_icon":0},{"id":"2517194729","title":"Arvinas, Inc.盘中异动 下午盘急速拉升5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517194729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517194729?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:38","pubTimestamp":1741289911,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时38分,Arvinas, Inc.股票出现异动,股价急速拉升5.20%。Arvinas, Inc.股票所在的生物技术行业中,整体跌幅为0.75%。Arvinas, Inc.公司简介:Arvinas Inc 是一家总部位于美国的生物制药公司,致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033831989ee96f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033831989ee96f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2517493229","title":"Arvinas, Inc.盘中异动 早盘股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517493229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517493229?lang=zh_cn&edition=full","pubTime":"2025-03-05 23:48","pubTimestamp":1741189728,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日23时48分,Arvinas, Inc.股票出现异动,股价快速上涨5.12%。Arvinas, Inc.股票所在的生物技术行业中,整体涨幅为1.49%。Arvinas, Inc.公司简介:Arvinas Inc 是一家总部位于美国的生物制药公司,致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305234848963aef75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305234848963aef75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2516654586","title":"Arvinas, Inc.盘中异动 下午盘股价大跌5.14%报16.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516654586?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:10","pubTimestamp":1741025417,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时10分,Arvinas, Inc.股票出现波动,股价急速下跌5.14%。截至发稿,该股报16.79美元/股,成交量40.2474万股,换手率0.59%,振幅6.64%。Arvinas, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。Arvinas, Inc.公司简介:Arvinas Inc 是一家总部位于美国的生物制药公司,致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021017abe6739c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021017abe6739c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2514874323","title":"Arvinas, Inc.盘中异动 大幅拉升5.08%报18.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514874323","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514874323?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:28","pubTimestamp":1740673739,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时28分,Arvinas, Inc.股票出现波动,股价急速上涨5.08%。截至发稿,该股报18.01美元/股,成交量24.8737万股,换手率0.36%,振幅5.81%。Arvinas, Inc.股票所在的生物技术行业中,整体涨幅为0.48%。Arvinas, Inc.公司简介:Arvinas Inc 是一家总部位于美国的生物制药公司,致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228002859a25696fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228002859a25696fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2514510868","title":"Arvinas, Inc.盘中异动 临近午盘急速跳水5.09%报16.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514510868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514510868?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:59","pubTimestamp":1740589154,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时59分,Arvinas, Inc.股票出现波动,股价大幅下跌5.09%。截至发稿,该股报16.77美元/股,成交量43.8865万股,换手率0.64%,振幅6.15%。Arvinas, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。Arvinas, Inc.公司简介:Arvinas Inc 是一家总部位于美国的生物制药公司,致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022700591496316adf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022700591496316adf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ARVN"],"gpt_icon":0},{"id":"2514464390","title":"Arvinas, Inc.盘中异动 临近收盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514464390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514464390?lang=zh_cn&edition=full","pubTime":"2025-02-26 04:31","pubTimestamp":1740515492,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日04时31分,Arvinas, Inc.股票出现波动,股价急速拉升5.01%。Arvinas, Inc.股票所在的生物技术行业中,整体涨幅为0.15%。Arvinas, Inc.公司简介:Arvinas Inc 是一家总部位于美国的生物制药公司,致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022604313398928e70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022604313398928e70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ARVN"],"gpt_icon":0},{"id":"2513041727","title":"Arvinas, Inc.盘中异动 股价大跌5.21%报16.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513041727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513041727?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:51","pubTimestamp":1740408671,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时51分,Arvinas, Inc.股票出现波动,股价大幅下挫5.21%。截至发稿,该股报16.85美元/股,成交量12.1291万股,换手率0.18%,振幅5.06%。Arvinas, Inc.股票所在的生物技术行业中,整体涨幅为0.08%。Arvinas, Inc.公司简介:Arvinas Inc 是一家总部位于美国的生物制药公司,致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225112a2521989&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225112a2521989&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ARVN"],"gpt_icon":0},{"id":"2513219311","title":"Arvinas, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513219311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513219311?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:45","pubTimestamp":1740163510,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时45分,Arvinas, Inc.股票出现波动,股价急速下挫5.01%。Arvinas, Inc.股票所在的生物技术行业中,整体涨幅为0.39%。Arvinas, Inc.公司简介:Arvinas Inc 是一家总部位于美国的生物制药公司,致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222024510988e1498&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222024510988e1498&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2512165363","title":"Arvinas, Inc.盘中异动 快速拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165363?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:38","pubTimestamp":1739889480,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时38分,Arvinas, Inc.股票出现波动,股价快速上涨5.30%。Arvinas, Inc.股票所在的生物技术行业中,整体涨幅为0.14%。Arvinas, Inc.公司简介:Arvinas Inc 是一家总部位于美国的生物制药公司,致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223800abd3b0a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223800abd3b0a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PULM","BK4007","ARVN"],"gpt_icon":0},{"id":"2511692603","title":"Arvinas, Inc.2024财年实现净利润-1.99亿美元,同比增加45.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511692603","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511692603?lang=zh_cn&edition=full","pubTime":"2025-02-15 00:00","pubTimestamp":1739548841,"startTime":"0","endTime":"0","summary":"2月15日,Arvinas, Inc.公布财报,公告显示公司2024财年净利润为-1.99亿美元,同比增加45.78%;其中营业收入为2.63亿美元,同比增加235.03%,每股基本收益为-2.77美元。从资产负债表来看,Arvinas, Inc.总负债5.30亿美元,其中短期债务2.00百万美元,资产负债比为2.06,流动比率为4.64。机构评级:截至2025年2月15日,当前有18家机构对Arvinas, Inc.目标价做出预测,其中目标均价为63.22美元,其中最低目标价为32.00美元,最高目标价为110.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215000115abcf1aec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215000115abcf1aec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arvinas.com","stockEarnings":[{"period":"1week","weight":0.0813},{"period":"1month","weight":-0.0403},{"period":"3month","weight":-0.004},{"period":"6month","weight":0.5941},{"period":"1year","weight":-0.2615},{"period":"ytd","weight":0.043}],"compareEarnings":[{"period":"1week","weight":0.0066},{"period":"1month","weight":-0.0027},{"period":"3month","weight":0.0113},{"period":"6month","weight":0.0592},{"period":"1year","weight":0.1509},{"period":"ytd","weight":0.008}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arvinas, Inc.于2013年2月根据特拉华州法律成立。该公司是一家生物制药公司,致力于通过发现、开发和商业化治疗降低致病蛋白质来改善患有衰弱和危及生命的疾病的患者的生活。该公司使用他们的专有技术平台来设计针对嵌合体或PROTAC的蛋白水解,这些嵌合体旨在利用人体自身的天然蛋白质处理系统来选择性地和有效地降解和去除致病蛋白质。Arvinas Holding Company,LLC相信他们的靶向蛋白质降解方法是一种新的治疗方式,可能提供优于现有方式的独特优势,包括传统的小分子疗法和基于基因的药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.038223},{"month":2,"riseRate":0.5,"avgChangeRate":0.000239},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.187738},{"month":4,"riseRate":0.571429,"avgChangeRate":0.096543},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.132272},{"month":6,"riseRate":0.857143,"avgChangeRate":0.012839},{"month":7,"riseRate":0.714286,"avgChangeRate":0.109648},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.06004},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.073956},{"month":10,"riseRate":0.5,"avgChangeRate":0.007881},{"month":11,"riseRate":0.75,"avgChangeRate":0.171233},{"month":12,"riseRate":0.5,"avgChangeRate":0.349087}],"exchange":"NASDAQ","name":"Arvinas Holding Company LLC","nameEN":"Arvinas Holding Company LLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arvinas Holding Company LLC(ARVN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arvinas Holding Company LLC(ARVN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arvinas Holding Company LLC,ARVN,Arvinas Holding Company LLC股票,Arvinas Holding Company LLC股票老虎,Arvinas Holding Company LLC股票老虎国际,Arvinas Holding Company LLC行情,Arvinas Holding Company LLC股票行情,Arvinas Holding Company LLC股价,Arvinas Holding Company LLC股市,Arvinas Holding Company LLC股票价格,Arvinas Holding Company LLC股票交易,Arvinas Holding Company LLC股票购买,Arvinas Holding Company LLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arvinas Holding Company LLC(ARVN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arvinas Holding Company LLC(ARVN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}